Company News

Share this article:

Sen. Chuck Grassley (R-IA) has written to Pfizer requesting details about payments the company made to 149 Harvard Medical School faculty members and doctors. A Pfizer spokesperson told the New York Times that the company “will fully cooperate with Senator Grassley's request for information.”

 

Vertex Pharmaceuticals has acquired Canadian drugmaker ViroChem Pharma for $100 million in cash, and 9.9 million shares of Vertex common stock. The acquisition adds two early-stage hepatitis C drugs to the company's portfolio, VCH-222 and VCH-759.

Share this article:
You must be a registered member of MMM to post a comment.

This compelling e-book shares a wealth of insights designed to help members of sales forces connect with elusive HCPs. An expanded version has also been created that includes video interviews and other multimedia content. Click here for access.